Zanganeh Maky
- SEC CIK
- 0001507650
No open-market purchases or sales filed in the past year.
Current role at each company
- PLSE Pulse Biosciences, Inc.Directoras of Jun 15, 2026
- SMMT Summit Therapeutics Inc.Co-Chief Executive Officeras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Zanganeh Maky as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SMMT Summit Therapeutics Inc.
Co-Chief Executive Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 (view filing) | Jun 12 | Same day | Zanganeh MakyCo-Chief Executive Officer | PPurchase | +3.81M | $13.12 | +$50.0M | +0.7%573.9M after | Duplicate filing |
| Jun 4, 2026 (view filing) | Jun 4 | Same day | Zanganeh MakyCo-Chief Executive Officer | PPurchase | +100.0K | $14.60 | +$1.46M | +0.4%25.8M after | Duplicate filing |
| Oct 23, 2025 (view filing) | Oct 21 | 2 days | Zanganeh MakyCo-Chief Executive Officer | PPurchase | +26.7K | $18.74 | +$500.0K | +53.4%76.7K after | Duplicate filing |
| Sep 11, 2025 (view filing) | Sep 10-11 | 1 day | Zanganeh MakyCo-Chief Executive Officer | PPurchase | +338.4K | $17.69 | +$5.98M | +0.1%556.1M after | 2 lotsDuplicate filing |
| Mar 27, 2024 (view filing) | Mar 27 | Same day | Zanganeh MakyChief Executive Officer | PPurchase | +26.0K | $3.72 | +$96.7K | +5.3%520.8K after | |
| Mar 27, 2024 (view filing) | Mar 26-27 | 1 day | Zanganeh MakyChief Executive Officer | PPurchase | +84.3K | $3.73 | +$314.4K | New position50.0K after | 3 lots |
| Dec 13, 2023 (view filing) | Dec 12 | 1 day | Zanganeh MakyChief Executive Officer | PPurchase | +5.00K | $2.07 | +$10.3K | +1.0%494.8K after | |
| Mar 13, 2023 (view filing) | Mar 8 | 5 days | Zanganeh MakyCo-CEO & President | PPurchase | +23.5M | $1.05 | +$24.7M | New position9.88M after | Amended2 lots |
| Mar 8, 2023 (view filing) | Mar 8 | Same day | Zanganeh MakyCo-CEO & President | PPurchase | +804.7K | $1.05 | +$844.9K | +215.2%1.18M after | From original |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Zanganeh MakyCo-CEO & President | PPurchase | +184.4K | $0.97 | +$178.9K | +105.1%360.0K after |
PLSE Pulse Biosciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2024 (view filing) | Jul 3 | 6 daysLate | Zanganeh MakyDirector | PPurchase | +60.2K | – | – | –30.1K after | Derivative2 lots |
| Jun 10, 2022 (view filing) | Jun 9 | 1 day | Zanganeh MakyDirector | PPurchase | +86.7K | – | – | –86.7K after | Derivative |